Literature DB >> 20889745

Draft genome sequence of Streptomyces clavuligerus NRRL 3585, a producer of diverse secondary metabolites.

Ju Yeon Song1, Haeyoung Jeong, Dong Su Yu, Michael A Fischbach, Hong-Seog Park, Jae Jong Kim, Jeong-Sun Seo, Susan E Jensen, Tae Kwang Oh, Kye Joon Lee, Jihyun F Kim.   

Abstract

Streptomyces clavuligerus is an important industrial strain that produces a number of antibiotics, including clavulanic acid and cephamycin C. A high-quality draft genome sequence of the S. clavuligerus NRRL 3585 strain was produced by employing a hybrid approach that involved Sanger sequencing, Roche/454 pyrosequencing, optical mapping, and partial finishing. Its genome, comprising four linear replicons, one chromosome, and four plasmids, carries numerous sets of genes involved in the biosynthesis of secondary metabolites, including a variety of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889745      PMCID: PMC2981214          DOI: 10.1128/JB.00859-10

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

Review 1.  New reactions in clavulanic acid biosynthesis.

Authors:  Craig A Townsend
Journal:  Curr Opin Chem Biol       Date:  2002-10       Impact factor: 8.822

2.  Rapid PCR amplification of minimal enediyne polyketide synthase cassettes leads to a predictive familial classification model.

Authors:  Wen Liu; Joachim Ahlert; Qunjie Gao; Evelyn Wendt-Pienkowski; Ben Shen; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

3.  Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

Authors:  A G Brown; D Butterworth; M Cole; G Hanscomb; J D Hood; C Reading; G N Rolinson
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

4.  Beta-lactam antibiotics from Streptomyces.

Authors:  R Nagarajan; L D Boeck; M Gorman; R L Hamill; C E Higgens; M M Hoehn; W M Stark; J G Whitney
Journal:  J Am Chem Soc       Date:  1971-05-05       Impact factor: 15.419

5.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd.

Authors:  R D Fleischmann; M D Adams; O White; R A Clayton; E F Kirkness; A R Kerlavage; C J Bult; J F Tomb; B A Dougherty; J M Merrick
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

6.  The biosynthetic genes for clavulanic acid and cephamycin production occur as a 'super-cluster' in three Streptomyces.

Authors:  J M Ward; J E Hodgson
Journal:  FEMS Microbiol Lett       Date:  1993-06-15       Impact factor: 2.742

7.  Complete nucleotide sequence of a linear plasmid from Streptomyces clavuligerus and characterization of its RNA transcripts.

Authors:  X Wu; K L Roy
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

8.  Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. I. Discovery and biological activity.

Authors:  D L Pruess; M Kellett
Journal:  J Antibiot (Tokyo)       Date:  1983-03       Impact factor: 2.649

9.  Holomycin and an antibiotic (MM 19290) related to tunicamycin, metabolites of Streptomyces clavuligerus.

Authors:  M Kenig; C Reading
Journal:  J Antibiot (Tokyo)       Date:  1979-06       Impact factor: 2.649

Review 10.  Indolocarbazole antitumour compounds by combinatorial biosynthesis.

Authors:  José A Salas; Carmen Méndez
Journal:  Curr Opin Chem Biol       Date:  2009-02-27       Impact factor: 8.822

View more
  24 in total

1.  A cost-effective and universal strategy for complete prokaryotic genomic sequencing proposed by computer simulation.

Authors:  Jingwei Jiang; Jun Li; Hoi Shan Kwan; Chun Hang Au; Patrick Tik Wan Law; Lei Li; Kai Man Kam; Julia Mei Lun Ling; Frederick C Leung
Journal:  BMC Res Notes       Date:  2012-01-31

2.  Carboxyethylarginine synthase genes show complex cross-regulation in Streptomyces clavuligerus.

Authors:  Thomas Kwong; Kapil Tahlan; Cecilia L Anders; Susan E Jensen
Journal:  Appl Environ Microbiol       Date:  2012-10-26       Impact factor: 4.792

3.  Genome sequence of an ammonia-oxidizing soil archaeon, "Candidatus Nitrosoarchaeum koreensis" MY1.

Authors:  Byung Kwon Kim; Man-Young Jung; Dong Su Yu; Soo-Je Park; Tae Kwang Oh; Sung-Keun Rhee; Jihyun F Kim
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

4.  High-throughput screening for Streptomyces antibiotic biosynthesis activators.

Authors:  Li Chen; Yemin Wang; Hang Guo; Min Xu; Zixin Deng; Meifeng Tao
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

5.  Impacts of horizontal gene transfer on the compact genome of the clavulanic acid-producing Streptomyces strain F613-1.

Authors:  Jun Li; Zhilong Zhao; Weihong Zhong; Chuanqing Zhong; Gongli Zong; Jiafang Fu; Guangxiang Cao
Journal:  3 Biotech       Date:  2018-11-08       Impact factor: 2.406

6.  Proteomics analysis of global regulatory cascades involved in clavulanic acid production and morphological development in Streptomyces clavuligerus.

Authors:  Nicole L Ferguson; Lourdes Peña-Castillo; Marcus A Moore; Dawn R D Bignell; Kapil Tahlan
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01-20       Impact factor: 3.346

Review 7.  Biosynthesis of clavam metabolites.

Authors:  Susan E Jensen
Journal:  J Ind Microbiol Biotechnol       Date:  2012-09-05       Impact factor: 3.346

Review 8.  Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics.

Authors:  Bo Li; Walter J Wever; Christopher T Walsh; Albert A Bowers
Journal:  Nat Prod Rep       Date:  2014-07       Impact factor: 13.423

9.  A natural plasmid uniquely encodes two biosynthetic pathways creating a potent anti-MRSA antibiotic.

Authors:  Daisuke Fukuda; Anthony S Haines; Zhongshu Song; Annabel C Murphy; Joanne Hothersall; Elton R Stephens; Rachel Gurney; Russell J Cox; John Crosby; Christine L Willis; Thomas J Simpson; Christopher M Thomas
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

10.  Genome-based studies of marine microorganisms to maximize the diversity of natural products discovery for medical treatments.

Authors:  Xin-Qing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.